Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

InnovAge Holding Corp. (INNV) Cash Flow Statement

InnovAge Holding Corp. (INNV) generated $64.7M of operating cash flow over the twelve months to 2026-06-30, spent $14.3M on capital expenditure and had free cash flow of $50.4M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

INNVInnovAge Holding Corp.Follow INNV — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
1.3B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
3 Nov, in 10 days
LineFY2021
Jun 21
FY2022
Jun 22
FY2023
Jun 23
FY2024
Jun 24
FY2025
Jun 25
FY2026
Jun 26
TTM
Jun 26
Trend
Operating cash flow-7.527.320.2-36.932.964.764.7
Capital expenditure17.538.223.47.96.314.3-14.3
Free cash flow-25.1-10.9-3.1-44.826.650.450.4
Dividends paid9.5——————
Share repurchases77.6——————
Stock-based compensation1.73.74.66.87.67.0—

USD millions · SEC XBRL

InnovAge Holding Corp. — questions

What is InnovAge Holding Corp.'s operating cash flow?
$64.7M over the twelve months to 2026-06-30.
How much does InnovAge Holding Corp. spend on capital expenditure?
$14.3M over the twelve months to 2026-06-30.
What is InnovAge Holding Corp.'s free cash flow?
$50.4M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from InnovAge Holding Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.